CME Enduring Material Quiz

  1. Becoming Whipped Up Over Flagellate Dermatoses

  2. Idiopathic Facial Aseptic Granuloma – Have We Met?

  3. Here Comes the Sun: The Role of Polypodium leucotomos Extract

  4. Linear and Whorled Nevoid Hypermelanosis: Past Reflections and Future Directions

  5. Difficulty Differentiating Palmar Psoriasis from Eczema: Can Dermatopathologists Lend a Hand?

  6. Diagnosis Calciphylaxis: A Better Way?

  7. Does He or Doesn’t He? Only His Oncologist Knows for Sure!

  8. Histologic Overreliance on Mucin for Diagnosis May Prove…Sticky

  9. Scratching Below the Surface for the Etiology of Lichen Amyloidosis – No Sweat?

  10. The Opioid Epidemic: Coma Blisters and Beyond

  11. Scarred by Dogma: Revising Recommendations for Surgery and Isotretinoin Use

  12. Methotrexate Toxicity: What’s in a Name?

  13. Naltrexone Therapy for Hailey-Hailey Disease: Confirming My Addiction to Evidence-Based Medicine

  14. Becker’s Nevus – Mutations that Shoulder Responsibility

  15.  Should Benign Cephalic Histiocytosis Be Renamed? Let’s Keep Our Heads about this Decision.

  16. Not Just for Boys: X-Linked Erythropoietic Protoporphyria

  17. Selectivity and the Choice of Beta-Blockers for Infantile Hemangiomas

  18. Alopecia Areata Incognita in Cronkhite-Canada Syndrome Suggests an Autoimmune Etiology – And That’s the Way It Is.

  19. The Ultimate Prognosis of Eosinophilic Fasciitis May Not Be Groovy

  20. Something from Nothing: The Role of Random Skin Biopsies

  21. Comprehending the Association of Orofacial Granulomatosis and Crohn Disease Would Be Swell

  22. Voriconazole Prophylaxis Mandates Cutaneous Prophylaxis – and Communication

  23. Yeast Rising: Predicting the Efficacy of Candida Antigen Immunotherapy for Warts

  24. Keeping Up is Hard to Do – the Need for True Grit

  25. The Journey of Focal Dermal Hypoplasia: From Description to Inspired Therapy

  26. Softening the Blow of Calcinosis Cutis: The Promise of Intralesional Sodium Thiosulfate

  27. Cyclosporine Reaches the Top of the SJS/TEN Leaderboard

  28. Countering Corticophobia with Assistance from Dr. Albert Kligman

  29. Incretin-Based Therapy for Diabetes and Dermatology: Promise and Peril 

  30. Considering Palmar Erythema Requires Memory (and Lane)

  31. Nailing the Diagnosis of Psoriatic Arthritis

  32. Cannabinoids May Elevate Therapy for Connective Tissues Diseases to a Higher Level

  33. The Concept of Atrophoderma of Pasini and Pierini as Morphea May be Falling off a Cliff

  34. Keeping an Eye on Retinoids as Treatment for the Ectropion of Lamellar Ichthyosis

  35. Of Every Possible Solution for Elastosis Perforans Serpiginosa, Fractional Carbon Dioxide Laser May Be the Best

  36. Understanding the Risk of Wilms Tumor in Hemihypertrophy: Are We Halfway There?

  37. Koebnerization in Henoch-Schönlein Purpura: How Does It Line Up with Prognosis?

  38. Parvovirus Infections: What’s Relevant?

  39. Memories of Pneumocystis Pneumonia and Thoughts of Prophylaxis

  40. Coming to an ICU near you – Candida auris

  41. APACHE No More

  42. Bringing Pigmented Lupus to Light

  43. What are Keratoacanthomatous Lesions of the Legs in Mature Women?

  44.  Crystallizing Thoughts about Crystalglobulinemia

  45. Hairdressers’ Dermatologic Odyssey: From Dye to Death Prevention

  46. The Term “Dermal Hyperneury” Hits a Nerve

  47. Brentuximab Vediton Update and the #MeToo Saga of the Reed-Sternberg Cell

  48. The Medical Word to Watch in 2018 – Dysbiosis

  49. Dupilumab: The First Year

  50. Adjusting the Screen Door: Developing a Rational Approach to Assessing for Thyroid Disease in Patients with Alopecia Areata

  51.  Say “Cheese”! Three Reasons Why EMR Photography Makes Me Smile

  52.  Prolactin and its Role in Stress-Induced Psoriasis: Milking the Data

  53. Time for a Churchillian Approach to Idiopathic Guttate Hypomelanosis?

  54. Cutaneous Green and E-A-G-L-E-S!

  55. Trial Balloons of Gene Expression Profiles of Balloon Cell Melanoma Predict the Future

  56. Itching to Prescribe the Right Treatment for Scabies: Topical Permethrin or Oral Ivermectin?

  57. Pondering Follicular Keratosis of the Chin

  58. Predicting Malignancies in Sweet Syndrome Has Become Sweeter

  59. My Diagnostic Blind Spot: Erythema Elevatum Diutinum

  60. Hidden in Plain Sight: Satoyoshi Syndrome

  61. The Challenge of Identifying Identical Twins: Advances in Differentiating Lupus Erythematosus Panniculitis from Subcutaneous Panniculitis-Like T-cell Lymphoma

  62. The Congenital Perineal Groove: Defective Recognition of a Dermal Defect

  63. Get Your KICS on Route IL-6

  64. Asking Psoriasis Patients to Open Their Mouths and Say “Ahhh”

  65. Oncolytic Virotherapy and the Dermatologist

  66. The Heartrending Aspects of Incontinentia Pigmenti

  67. Malassezia Folliculitis: Simultaneously Seen and Invisible

  68. No Need for Panic with MANIC

  69. Ultraviolet Light, Adipose Tissue, and Fantasies of Summer

  70. Contemplating the Association of Hydrochlorothiazide to Nonmelanoma Skin Cancer Raises My Blood Pressure

  71. Clawing to Understand Lichen Nitidus

  72. Dyeing for a “New” Topical Agent for Psoriasis? Think Indigo

  73. Shades of Shelley: Azithromycin Therapy for Erythema Annulare Centrifugum

  74. The Appeal of Molecular Medicine for the Peeling Skin Syndrome

  75. As Molecular Knowledge of PROS Expands, Lesions Contract